We could prevent diseases so much better but we haven't learned to listen to when biology whispers long (10 + years) in advance. A key theme in Super Agers, too.
https://t.co/0pSap3f32N @NathanPriceSci @ @nrappapo@BuckInstitute example below for Type 2 diabetes
Good that you posted a response, Peter. Agree, there is no defense for the now public and egregious interactions you had with Epstein.
But the man you are today vs 10 years ago has not changed w/r to arrogance. Moreover, these days you are riddled with conflicts as a huckster for David Bars, AG-1 supplement, and so many other things that diminish your credibility. That's a shame.
@EricTopol@AnnalsofIM If you’ve lost 20 or 120+pounds, I’ll remind you that you used to carry that weight around every day before you lost that weight. People with obesity are actually quite strong! Once they’ve lost weight, they’re even stronger. When you measure it and track it, you’ll see it 🏆
@EricTopol 3X current highest dose (7.2 mg weekly was studied, Wegovy (Semaglutide) is currently offered at highest dose of 2.4 mg weekly and Ozempic is currently approved for up to 2 mg weekly).
I hope we as a society are moving the needle on cancer incidence.
I remember when we all, and still do, celebrate metformin as an "anti-cancer" drug, associated with 10% cancer reduction in the Look AHEAD trial 👉https://t.co/UOb1hWHReo
25-47% reduction in certain cancers sound wildly large. Now we just need to get #GLP1s in the hands of populations #access @EliLillyandCo@novonordiskus
https://t.co/gppD5mmrAR
@DrNadolsky I love this. Especially the column titled “diet food” on the “GET BIG!” Program. Well done! If we had your Testosterone and IGF1 levels from then and now, we could try refeeding you on this plan and see what happens
I am thrilled to share our @ACCinTouch Expert Consensus Statement and Concise Clinical Guidance on Medical #WeightManagement
⭐️ https://t.co/GrM7oTxpK3
Special highlights:
👉GLP1 is just the beginning. Myriads of gut hormone permutations necessitate broader acceptance of the umbrella term: NuSH, nutrient-stimulated hormone
👉We reinforced sex- and ethnic-specific cutoffs for anthropometric measures of excess fat
👉Aligning with #obesity as a chronic disease, the patient’s highest lifetime non-pregnant weight should be considered their diagnostic baseline
👉 Any dose of #NuSH medication can be a maintenance dose, which is supported by our general ethical practice to Do No Harm and to use the lowest therapeutic dose to mitigate risks of side effects
Co-written with my esteemed colleagues @DrMarthaGulati@DrOliviaGilbert@tygluckman@MKIttlesonMD@RishiRikhiMD and Joseph Saseen, we aimed to create a guidance for the #cardiology and #obesity communities that is as practical as possible. Clinicians should be able to quote directly from this Statement to appeal to payers and increase #access to high quality care.
The obesity space in the US has been desperate for an update to our 2013 AHA/ACC/TOS guidelines. Think of this as a preview!
@operationdanish Precision Medical forecasting and early intervention with targeted therapy (before onset of chronic disease) is the way. I’m grateful that you’re highlighting the opportunity to change your healthspan with the support of a longevity doctor 🎯 (and I can offer a second opinion!)
@davidasinclair 80% of men over age 80 have prostate cancer. I agree with genetic testing and screening. It’s likely he’s known about this cancer for some time. One can be “fit to serve” with cancer.